Novavax IncAdd to My Watchlist

NVAX:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 1.48
  • 0.03  -1.99%
    Today's Change
  • 1.51
    Previous Close
  • Today
    52 Week Low - High
8:10 pm ET 7/21/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding283 million
Market Cap$418 million
Return on Equity ttm--
Last DividendNVAX:US does not pay a dividend
EPS: Year Actual ttm-0.900
EPS: Year Est. 12/17 ttm-0.612
EPS: Quarterly Actual 3/17 -0.16
EPS: Quarterly Est. 6/17 -0.16
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-71.67
Company Description
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Revenue$15 million
Net Income$-280 million
Total Assets$394 million

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!